Annual report
4502.TEDINET S100YB5L
Period2025-04-01 → 2026-03-31
Filed2026-06-17
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.51T | 2025-04-01 → 2026-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.58T | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.26T | 2023-04-01 → 2024-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥4.03T | 2022-04-01 → 2023-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.57T | 2021-04-01 → 2022-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥6.2bn | 2025-04-01 → 2026-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥342.6bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥142.4bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥175.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥52.8bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥375.1bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥302.6bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | −¥152.4bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥107.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥144.1bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥317.0bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥230.1bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | −¥152.1bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥108.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥144.2bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥317.0bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥230.2bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥15.51T | at 2026-03-31 | Cons. | Assets IFRS |
| Total assets | ¥14.25T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥15.11T | at 2024-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥13.96T | at 2023-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥13.18T | at 2022-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥8.08T | at 2026-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥7.31T | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥7.43T | at 2026-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥6.94T | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥7.27T | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥7.43T | at 2026-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥6.94T | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥595.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥385.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥457.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥533.5bn | at 2023-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥849.7bn | at 2022-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥1.04T | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.06T | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥716.3bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥977.2bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.12T | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥369.1bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥367.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥463.9bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥607.1bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥198.1bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥496.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥751.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥354.4bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥709.1bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.07T | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥-96.75 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥68.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥92.09 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥204.29 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥147.14 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-96.75 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥67.23 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥91.16 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥201.94 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥145.87 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥4,702.66 | at 2026-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,407.01 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,635.56 | at 2024-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,087.49 | at 2023-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,665.61 | at 2022-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 47.9% | at 2026-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.7% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2023-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.1% | at 2022-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | -2.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 2.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.3% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.2% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 47,029 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 47,455 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 49,281 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 49,095 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 47,347 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥591.6bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥580.4bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥595.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥632.1bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥764.3bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥21.1bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥36.9bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥205.5bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥86.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥286.4bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥340.1bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥550.9bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥187.0bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥199.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥197.3bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥152.8bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥338.9bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥330.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥324.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.64T | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥9.49T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥9.76T | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.41T | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.64T | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.88T | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.50T | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.76T | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.99T | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.09T | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥4.21T | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.29T | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥73.9bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥169.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥125.29 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥96.79 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥216.6 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.06 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.5 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥125.26 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥96.78 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.56 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥213.05 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥207.5 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥200 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥196 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥188 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,378.68 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,534.39 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,604.87 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,704.87 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,769.31 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 39.0% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.9% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.1% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,591,229,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,590,950,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,419,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,296,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,253,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,792 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 4,808 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 5,474 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 5,486 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 5,149 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2026-03-31 | 47029 pure |
| Pharmaceutical Businessreportable segment | employees | at 2026-03-31 | 4792 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,774
| Item | Context | Value | Unit |
|---|---|---|---|
| Gain on sale of investments in subsidiaries IFRS | Prior1YearDuration | 6081000000 | JPY |
| Gain on sale of investments in subsidiaries IFRS | CurrentYearDuration | 18265000000 | JPY |
| Other other income IFRS | Prior1YearDuration | 13262000000 | JPY |
| Other other income IFRS | CurrentYearDuration | 6318000000 | JPY |
| Other income IFRS | Prior1YearDuration | 26212000000 | JPY |
| Other income IFRS | CurrentYearDuration | 24747000000 | JPY |
| Donations IFRS | Prior1YearDuration | 7663000000 | JPY |
| Donations IFRS | CurrentYearDuration | 6866000000 | JPY |
| Restructuring expenses IFRS | Prior1YearDuration | 128133000000 | JPY |
| Restructuring expenses IFRS | CurrentYearDuration | 70818000000 | JPY |
| Change in fair value of contingent considerations other operating expense IFRS | Prior1YearDuration | 1788000000 | JPY |
| Change in fair value of contingent considerations other operating expense IFRS | CurrentYearDuration | 1006000000 | JPY |
| Valuation reserve for pre launch inventories reversal IFRS | Prior1YearDuration | -7313000000 | JPY |
| Valuation reserve for pre launch inventories reversal IFRS | CurrentYearDuration | 50984000000 | JPY |
| Impairment of assets held for sale other operating expense IFRS | Prior1YearDuration | 6812000000 | JPY |
| Impairment of assets held for sale other operating expense IFRS | CurrentYearDuration | 1363000000 | JPY |
| Other other expenses IFRS | Prior1YearDuration | 69650000000 | JPY |
| Other other expenses IFRS | CurrentYearDuration | 24466000000 | JPY |
| Other expenses IFRS | Prior1YearDuration | 206733000000 | JPY |
| Other expenses IFRS | CurrentYearDuration | 558979000000 | JPY |
| Financial assets measured at amortized cost interest income IFRS | Prior1YearDuration | 15183000000 | JPY |
| Financial assets measured at amortized cost interest income IFRS | CurrentYearDuration | 13184000000 | JPY |
| Financial assets measured at fair value through profit or loss interest income IFRS | Prior1YearDuration | 3062000000 | JPY |
| Financial assets measured at fair value through profit or loss interest income IFRS | CurrentYearDuration | 291000000 | JPY |
| Interest income on sublease interest income IFRS | Prior1YearDuration | 0 | JPY |
| Interest income on sublease interest income IFRS | CurrentYearDuration | － | JPY |
| Financial assets measured at fair value through other comprehensive income dividend income IFRS | Prior1YearDuration | 1000000 | JPY |
| Financial assets measured at fair value through other comprehensive income dividend income IFRS | CurrentYearDuration | 1000000 | JPY |
| Equity instruments designated as measured at fair value through other comprehensive income dividend income IFRS | Prior1YearDuration | 344000000 | JPY |
| Equity instruments designated as measured at fair value through other comprehensive income dividend income IFRS | CurrentYearDuration | 345000000 | JPY |
| Derivative foreign currency exchange IFRS | Prior1YearDuration | 7999000000 | JPY |
| Derivative foreign currency exchange IFRS | CurrentYearDuration | 179648000000 | JPY |
| Virtual power purchase agreement finance income IFRS | Prior1YearDuration | 4959000000 | JPY |
| Virtual power purchase agreement finance income IFRS | CurrentYearDuration | 1071000000 | JPY |
| Interest rate swap finance income IFRS | Prior1YearDuration | 2968000000 | JPY |
| Interest rate swap finance income IFRS | CurrentYearDuration | － | JPY |
| Cross currency interest rate swap IFRS | Prior1YearDuration | 3856000000 | JPY |
| Cross currency interest rate swap IFRS | CurrentYearDuration | － | JPY |
| Other finance income IFRS | Prior1YearDuration | 6784000000 | JPY |
| Other finance income IFRS | CurrentYearDuration | 13235000000 | JPY |
| Finance income IFRS | Prior1YearDuration | 46549000000 | JPY |
| Finance income IFRS | CurrentYearDuration | 211177000000 | JPY |
| Interest expense on financial debt interest expense IFRS | Prior1YearDuration | 112800000000 | JPY |
| Interest expense on financial debt interest expense IFRS | CurrentYearDuration | 123758000000 | JPY |
| Interest expense on lease liabilities interest expense IFRS | Prior1YearDuration | 24511000000 | JPY |
| Interest expense on lease liabilities interest expense IFRS | CurrentYearDuration | 24366000000 | JPY |
| Virtual power purchase agreement finance costs IFRS | Prior1YearDuration | 5311000000 | JPY |
| Virtual power purchase agreement finance costs IFRS | CurrentYearDuration | 3675000000 | JPY |
| Foreign exchange loss IFRS | Prior1YearDuration | 7213000000 | JPY |
| Foreign exchange loss IFRS | CurrentYearDuration | 171254000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |